Gabapentin CAS 60142-96-3 | High-Purity Pharmaceutical API
The specific mechanism of action of gabapentin is rather unique. Although it is structurally similar to the inhibitory neurotransmitter GABA, it does not exert its effects through GABA receptors. It is currently believed that its primary target is the α2δ subunit of voltage-dependent calcium channels in the central nervous system. By binding to this subunit, gabapentin reduces the influx of calcium ions, thereby regulating the release of various neurotransmitters and ultimately producing anticonvulsant, analgesic, and anxiolytic effects.
Epilepsy: Adjunctive Therapy for Partial Seizures
Gabapentin is approved for the adjunctive treatment of partial seizures (with or without secondary generalized seizures) in adults and children aged 3 years and older. This means it is typically used in combination with other antiepileptic drugs to better control seizures.